Arcutis Biotherapeutics【ARQT】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

15.24

買値

15.22

売値

15.26

出来高

741,889

14.92 日の範囲 15.57

6.99 52 週間の範囲 17.75

時価総額

1.808B

前日終値

15.64

始値

15.57

時刻

15.24

最終取引時間

02:48:24

財務取引量

US$ 11,320,824

VWAP

15.2595

平均取引量 (3 か月)

2,370,007

発行済株式数

118,638,235

配当利回り

PER

-12.96

1 株当たり利益 (EPS)

-1.18

歳入

196.54M

純利益

-140.04M

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targe... Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate, roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.arcutis.com

本社

Wilmington, Delaware, USA

設立

Arcutis Biotherapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker ARQT. The last closing price for Arcutis Biotherapeutics was US$15.64. Over the last year, Arcutis Biotherapeutics shares have traded in a share price range of US$ 6.99 to US$ 17.75.

Arcutis Biotherapeutics currently has 118,638,235 shares in issue. The market capitalisation of Arcutis Biotherapeutics is US$1.86 billion. Arcutis Biotherapeutics has a price to earnings ratio (PE ratio) of -12.96.

全体の流れ

ブルリッシュ

ネットプレミアム

94k

Calls / Puts

300.00%

買い / 売り

0.00%

OTM / ITM

33.33%

Sweeps比率

0.00%

Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference

WESTLAKE VILLAGE, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and...

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a...

Form 4 - Statement of changes in beneficial ownership of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-2.4	-13.6054421769	17.64	17.75	14.76	2105713	16.26948502	CS
4	2.64	20.9523809524	12.6	17.75	12.25	2590522	15.79478882	CS
12	0.11	0.727032385988	15.13	17.75	11.13	2370007	14.19417353	CS
26	5.97	64.4012944984	9.27	17.75	8.03	2178612	12.69459398	CS
52	5.28	53.0120481928	9.96	17.75	6.99	2392259	10.92735819	CS
156	-4.06	-21.0362694301	19.3	27.4	1.76	2008835	9.36223548	CS
260	-13.92	-47.7366255144	29.16	39.8527	1.76	1273654	10.30727688	CS

ARQT - Frequently Asked Questions (FAQ)

What is the current Arcutis Biotherapeutics share price?

The current share price of Arcutis Biotherapeutics is US$ 15.24

How many Arcutis Biotherapeutics shares are in issue?

Arcutis Biotherapeutics has 118,638,235 shares in issue

What is the market cap of Arcutis Biotherapeutics?

The market capitalisation of Arcutis Biotherapeutics is USD 1.86B

What is the 1 year trading range for Arcutis Biotherapeutics share price?

Arcutis Biotherapeutics has traded in the range of US$ 6.99 to US$ 17.75 during the past year

What is the PE ratio of Arcutis Biotherapeutics?

The price to earnings ratio of Arcutis Biotherapeutics is -12.96

What is the cash to sales ratio of Arcutis Biotherapeutics?

The cash to sales ratio of Arcutis Biotherapeutics is 9.24

What is the reporting currency for Arcutis Biotherapeutics?

Arcutis Biotherapeutics reports financial results in USD

What is the latest annual turnover for Arcutis Biotherapeutics?

The latest annual turnover of Arcutis Biotherapeutics is USD 196.54M

What is the latest annual profit for Arcutis Biotherapeutics?

The latest annual profit of Arcutis Biotherapeutics is USD -140.04M

What is the registered address of Arcutis Biotherapeutics?

The registered address for Arcutis Biotherapeutics is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810

What is the Arcutis Biotherapeutics website address?

The website address for Arcutis Biotherapeutics is www.arcutis.com

Which industry sector does Arcutis Biotherapeutics operate in?

Arcutis Biotherapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

銘柄コード	株価	出来高
RSLSReShape Lifesciences Inc	US$ 2.45 (579.61%)	207.81M
BIAFbioAffinity Technologies Inc	US$ 1.3399 (415.35%)	422.15M
CSAICloudastructure Inc	US$ 9.295 (109.35%)	40.27M
ICCTiCoreConnect Inc	US$ 4.12 (83.93%)	181.25M
GATEMarblegate Acquisition Corporation	US$ 36.05 (83.83%)	159.59k
GDHGGolden Heaven Group Holdings Ltd	US$ 0.73 (-84.50%)	13.51M
TBHBrag House Holdings Inc	US$ 1.345 (-79.65%)	3.2M
CMBMCambium Networks Corporation	US$ 0.3482 (-50.64%)	1.79M
APTOAptose Biosciences Inc	US$ 1.65 (-47.62%)	521.89k
LPROOpen Lending Corporation	US$ 1.4695 (-46.76%)	12.07M
BIAFbioAffinity Technologies Inc	US$ 1.3399 (415.35%)	422.15M
STSSSharps Technology Inc	US$ 0.02765 (-7.53%)	314.22M
DMNDamon Inc	US$ 0.0125 (-9.42%)	266.26M
RSLSReShape Lifesciences Inc	US$ 2.45 (579.61%)	207.81M
ICCTiCoreConnect Inc	US$ 4.12 (83.93%)	181.25M

銘柄コード

株価

出来高